Earlier this year, the Government of Canada introduced Bill C-64, the Pharmacare Act, which puts forward the plan for the first phase of national, universal pharmacare in Canada.

What does this mean for employers whose benefit plans may overlap with the proposed national coverage?

Join us for the latest details on C-64, the anticipated challenges and learn more about how private plans and their stakeholders are affected by this new program. You'll have a better understanding of the complex factors at play, and insights to better navigate the changing landscape of national pharmacare implementation.

Learning Objectives:

• Get an overview of the status of Canada's national pharmacare Bill C-64
• Understand the potential impacts of national pharmacare on private plans and their stakeholders
• Be better positioned to respond to leader and employee questions on the impacts of C-64 on coverage and plan costs and sustainability

Presented by:

Frédéric Leblanc

Pharmacist, Strategic Leader, Drug Programs

iA Financial Group

Frédéric Leblanc has been acting as Strategic Leader, Drug Programs, at iA Financial Group since 2019.

His expertise puts him at the heart of drug management strategies for our group insurance clients. 

In addition, he actively contributes to strengthening iA Financial Group's industry leadership position through optimal and innovative drug insurance plan management. 

Frédéric has over 20 years’ experience in the pharmaceutical industry. He has worked in fields such as drug development, product management and reimbursement, business development and government relations.

A member of the Ordre des pharmaciens du Québec, Frédéric Leblanc holds a bachelor's degree in pharmacy from the Université de Montréal and a graduate degree in pharmacoeconomics.

Please note that this session will be available also on-demand.

Are you attending several sessions? It may be worth it to RENEW OR SIGN UP FOR A CPBI MEMBERSHIP

Comments? Questions? Email us! [email protected]